MedTrace Logo

Cognitive Impairment and Outcome of Acute Ischemic Stroke.

NCT04235920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-06-23

No results posted yet for this study

Summary

The aim of this study is to assess the use of ASPECTS and stroke biomarkers to predict the outcome and cognitive impairment in acute ischemic stroke.

Conditions

Interventions

DIAGNOSTIC_TEST

Montreal Cognitive Assessment (MoCA)

This scale evaluates different domains of cognition like attention, orientation, memory, language, visuoconstructional capacities, and lastly, executive functions. MoCA is a thirty point test with a score of 25 or less considered as abnormal impaired cognition

Sponsors & Collaborators

  • Mansoura University Hospital

    lead OTHER

Principal Investigators

  • Esmael M Ahmed, MD · Assistant Prof of Neurology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2019-01-31
Completion
2019-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04235920 on ClinicalTrials.gov